Results from the BETTER WISE trial: a pragmatic cluster two arm parallel randomized controlled trial for primary prevention and screening in primary care during the COVID-19 pandemic
- PMID: 37770854
- PMCID: PMC10537846
- DOI: 10.1186/s12875-023-02159-6
Results from the BETTER WISE trial: a pragmatic cluster two arm parallel randomized controlled trial for primary prevention and screening in primary care during the COVID-19 pandemic
Abstract
Background: Cancer and chronic diseases are a major cost to the healthcare system and multidisciplinary models with access to prevention and screening resources have demonstrated improvements in chronic disease management and prevention. Research demonstrated that a trained Prevention Practitioner (PP) in multidisciplinary team settings can improve achievement of patient level prevention and screening actions seven months after the intervention.
Methods: We tested the effectiveness of the PP intervention in a pragmatic two-arm cluster randomized controlled trial. Patients aged 40-65 were randomized at the physician level to an intervention group or to a wait-list control group. The intervention consisted of a patient visit with a PP. The PP received training in prevention and screening and use of the BETTER WISE tool kit. The effectiveness of the intervention was assessed using a composite outcome of the proportion of the eligible prevention and screening actions achieved between intervention and control groups at 12-months.
Results: Fifty-nine physicians were recruited in Alberta, Ontario, and Newfoundland and Labrador. Of the 1,005 patients enrolled, 733 (72.9%) completed the 12-month analysis. The COVID-19 pandemic occurred during the study time frame at which time nonessential prevention and screening services were not available and in-person visits with the PP were not allowed. Many patients and sites did not receive the intervention as planned. The mean composite score was not significantly higher in patients receiving the PP intervention as compared to the control group. To understand the impact of COVID on the project, we also considered a subset of patients who had received the intervention and who attended the 12-month follow-up visit before COVID-19. This assessment demonstrated the effectiveness of the BETTER visits, similar to the findings in previous BETTER studies.
Conclusions: We did not observe an improvement in cancer and chronic disease prevention and screening (CCDPS) outcomes at 12 months after a BETTER WISE prevention visit: due to the COVID-19 pandemic, the study was not implemented as planned. Though benefits were described in those who received the intervention before COVID-19, the sample size was too small to make conclusions. This study may be a harbinger of a substantial decrease and delay in CCDPS activities under COVID restrictions.
Trial registration: ISRCTN21333761. Registered on 19/12/2016. http://www.isrctn.com/ISRCTN21333761 .
Keywords: COVID-19; Canada; Cancer survivors; Chronic disease; Clinical practice guidelines; Clinical trial; Prevention; Primary care; Screening.
© 2023. BioMed Central Ltd., part of Springer Nature.
Conflict of interest statement
DPM, EG, AL, and CF are Directors of a Canadian not-for-profit organization, The BETTER Institute, which provides training and implementation support to practices, organizations, and communities interested in adopting or adapting the BETTER approach. There are no other competing interests. All remaining authors do not have any competing interest.
Figures
Similar articles
-
The BETTER WISE protocol: building on existing tools to improve cancer and chronic disease prevention and screening in primary care for wellness of cancer survivors and patients - a cluster randomized controlled trial embedded in a mixed methods design.BMC Cancer. 2018 Sep 26;18(1):927. doi: 10.1186/s12885-018-4839-y. BMC Cancer. 2018. PMID: 30257655 Free PMC article. Clinical Trial.
-
Prevention and screening during the COVID-19 pandemic: qualitative findings from the BETTER WISE project.BMC Prim Care. 2023 Jan 23;24(1):27. doi: 10.1186/s12875-022-01954-x. BMC Prim Care. 2023. PMID: 36690937 Free PMC article.
-
What is a prevention visit? A qualitative study of a structured approach to prevention and screening - the BETTER WISE project.BMC Fam Pract. 2021 Jul 19;22(1):153. doi: 10.1186/s12875-021-01503-y. BMC Fam Pract. 2021. PMID: 34275453 Free PMC article.
-
Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.Health Technol Assess. 2020 Sep;24(46):1-490. doi: 10.3310/hta24460. Health Technol Assess. 2020. PMID: 32975190 Free PMC article.
-
BETTER LIFE- guidelines for chronic disease preventive care for people aged 18-39 years: a literature review.BMC Prim Care. 2024 Jun 22;25(1):224. doi: 10.1186/s12875-024-02471-9. BMC Prim Care. 2024. PMID: 38909200 Free PMC article. Review.
Cited by
-
Harmonization of clinical practice guidelines for primary prevention and screening: actionable recommendations and resources for primary care.BMC Prim Care. 2024 May 6;25(1):153. doi: 10.1186/s12875-024-02388-3. BMC Prim Care. 2024. PMID: 38711031 Free PMC article. Review.
-
Chronic disease prevention and screening outcomes for patients with and without financial difficulty: a secondary analysis of the BETTER WISE cluster randomised controlled trial.BMJ Open. 2024 Apr 15;14(4):e078938. doi: 10.1136/bmjopen-2023-078938. BMJ Open. 2024. PMID: 38626970 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous